European Society of Cardiology: Olezarsen Reduces Levels of the Blood Fat, Triglycerides, in Patients at High Cardiovascular Risk
August 30, 2025
August 30, 2025
SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release:
* * *
Olezarsen reduces levels of the blood fat, triglycerides, in patients at high cardiovascular risk
* An unmet need exists for effective therapies to lower triglyceride levels in patients with residual cardiovascular risk despite optimal lipid-lowering therapies.
* The ESSENCE-TIMI 73b trial investigated the efficacy and safety of the . . .
* * *
Olezarsen reduces levels of the blood fat, triglycerides, in patients at high cardiovascular risk
* An unmet need exists for effective therapies to lower triglyceride levels in patients with residual cardiovascular risk despite optimal lipid-lowering therapies.
* The ESSENCE-TIMI 73b trial investigated the efficacy and safety of the . . .